CD19 Chimeric Receptor Expressing T Lymphocytes In B-Cell Non Hodgkin's Lymphoma, ALL & CLL (CRETI-NH)

This study is currently recruiting participants.
Verified March 2014 by Baylor College of Medicine
Texas Children's Hospital
Houston Methodist Hospital
Center for Cell and Gene Therapy, Baylor College of Medicine
Information provided by (Responsible Party):
Carlos Ramos, Baylor College of Medicine Identifier:
First received: December 21, 2007
Last updated: March 28, 2014
Last verified: March 2014
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: February 2033
  Estimated Primary Completion Date: February 2018 (Final data collection date for primary outcome measure)